PUBLIC COMPANY
save$MISTMilestone Pharmaceuticals Inc.
$MISTMontreal, Quebec, CAupdated 3mo ago
community read0 votes
pipeline
1
marketed
1
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
- phase2ReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2
- phase3Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).
- phase3Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
🐶 Hiring Signal
News
- Milestone cuts 20% of staff as Cardamyst sales hit $1M in Q3Milestone Pharmaceuticals is cutting costs and staff following the FDA approval of its heart arrhythmia treatment, with two top executives departing the leadership team. The company said in its thi…endpoints · 5d ago
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that